SUO 2019: Update on Adjuvant Trials and the CTC
SUO 2019 adjuvant trials for renal cell carcinoma (RCC) within the CTC, PROSPER RCC, iMotion010, immunotherapy focused perioperative trials in RCC, S-TRAC, SUO-CTC
Related Articles
A Free Method for Patient-Specific 3D-VR Anatomical Modeling for Presurgical Planning Using DICOM Images and Open-Source Software – Beyond the Abstract
Patient-Specific 3D-VR Anatomical Modeling, DICOM Images, Patient-Specific 3D-VR Anatomical Modeling for Presurgical Planning Using DICOM Images and Open-Source Software, PSMA PET/CT, 99mTc-PSMA-I&S, salvage pelvic lymph…
Evolution of Chemohormonal Therapy for Metastatic Prostate Cancer – Pedro Barata
Zachary Klaassen speaks with Pedro Barata about chemohormonal therapy and treatment intensification for metastatic hormone-sensitive prostate cancer. Dr. Barata traces the evolution from 2015 when…
PRIMARY Score and Where it Plays a Role in Prostate Cancer Diagnosis “Presentation” – Michael Hofman
At the 2025 UCSF-UCLA PSMA Conference, Michael Hofman presents the PRIMARY score for PSMA PET in prostate cancer diagnosis. He explains how PSMA PET complements…
Tumor Dosimetry in PSMA Therapy: A VISION Substudy Analysis – Ken Herrmann
Oliver Sartor host Ken Herrmann to discuss tumor dosimetry findings from a VISION trial substudy examining lutetium PSMA therapy in prostate cancer patients. Dr. Herrmann…
Can PSMA-Targeted Prostate Biopsy Detect Cancer When MRI-Guided Biopsy is Negative? “Presentation” – Wayne Brisbane
At the 2025 UCSF-UCLA PSMA Conference, Wayne Brisbane presents a phase I trial examining PSMA-targeted prostate biopsy following negative/discordant MRI biopsies. Among 39 patients with…
PRECISION Data Platform Reveals mCRPC Treatment Outcomes in Urology Practices – Neal Shore
Zachary Klaassen interviews Neal Shore about real-world treatment patterns for mCRPC patients in community urology centers using the PRECISION database. Dr. Shore analyzes data from…
Risk Stratification for Active Surveillance in Low and Intermediate-Risk Bladder Cancer – Marco Moschini
Ashish Kamat speaks with Marco Moschini about expanding active surveillance criteria for recurrent low-grade bladder cancer. Dr. Moschini presents his single-center retrospective study from San…
Initial Linguistic and Cultural Validation of the Satisfaction Survey for Inflatable Penile Implant (SSIPI) in Spanish – Beyond the Abstract
erectile dysfunction, inflatable penile prosthesis (IPP), Satisfaction Survey for Inflatable Penile Implant (SSIPI), better patient care for Spanish speaking individuals undergoing inflatable penile prosthesis surgery.
Optimizing Treatment in Metastatic Hormone-Sensitive Prostate Cancer: A Case Study Analysis – Alicia Morgans
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Alicia…
Landscape of Approved and Upcoming PSMA Imaging Agents “Presentation” – Amir Iravani
At the 2025 UCSF-UCLA PSMA Conference, Amir Iravani compares FDA-approved PSMA PET agents (gallium-68 PSMA-11, DCFPyL, rhPSMA-7.3) for prostate cancer imaging. Dr. Iravani notes similar…